Abstract:To utilize metabolomics in conjunction with RNA sequencing to identify biomarkers in the blood of sepsis patients and discover novel targets for diagnosing and treating sepsis. In January 2019 and December 2020, blood samples were collected from a cohort of 16 patients diagnosed with sepsis and 11 patients diagnosed with systemic inflammatory response syndrome (SIRS). Non-targeted metabolomics analysis was conducted using liquid chromatography coupled with mass spectrometry (LC–MS/MS technology), while gene sequencing was performed using RNA sequencing. Afterward, the metabolite data and sequencing data underwent quality control and difference analysis, with a fold change (FC) greater than or equal to 2 and a false discovery rate (FDR) less than 0.05.Co-analysis was then performed to identify differential factors with consistent expression trends based on the metabolic pathway context; KEGG enrichment analysis was performed on the crossover factors, and Meta-analysis of the targets was performed at the transcriptome level using the public dataset. In the end, a total of five samples of single nucleated cells from peripheral blood (two normal controls, one with systemic inflammatory response syndrome, and two with sepsis) were collected and examined to determine the cellular location of the essential genes using 10× single cell RNA sequencing (scRNA-seq). A total of 485 genes and 1083 metabolites were found to be differentially expressed in the sepsis group compared to the SIRS group. Among these, 40 genes were found to be differentially expressed in both the metabolome and transcriptome. Functional enrichment analysis revealed that these genes were primarily involved in biological processes related to inflammatory response, immune regulation, and amino acid metabolism. Furthermore, a meta-analysis identified four genes, namely ITGAM, CD44, C3AR1, and IL2RG, which were highly expressed in the sepsis group compared to the normal group ( P < 0.05). Additionally, scRNA-seq analysis revealed that the core genes ITGAM and C3AR1 were predominantly localized within the macrophage lineage. The primary genes ITGAM and C3AR1 exhibit predominant expression in macrophages, which play a significant role in inflammatory and immune responses. Moreover, these genes show elevated expression levels in the plasma of individuals with sepsis, indicating their potential as valuable subjects for further research in sepsis.

Prognostic biomarkers for sepsis mortality based on the literature and LC-MS-based metabolomics of sepsis patients.

Multi-biomarker Strategy for Prediction of Myocardial Dysfunction and Mortality in Sepsis

Landscape of Metabolic Fingerprinting for Diagnosis and Risk Stratification of Sepsis

Serum metabolite profiling reveals metabolic characteristics of sepsis patients using LC/MS-based metabolic profiles: a cross-sectional study

Identification of metabolomics-based prognostic prediction models for ICU septic patients

Discrimination of Sepsis Stage Metabolic Profiles with an LC/MS-MS-based Metabolomics Approach.

Identification Of Novel Biomarkers For Sepsis Prognosis Via Urinary Proteomic Analysis Using Itraq Labeling And 2d-Lc-Ms/Ms

POS-182 SDF4 IS A PROGNOSTIC FACTOR FOR 28-DAYS MORTALITY IN PATIENTS WITH SEPSIS VIA NEGATIVELY REGULATING ER STRESS

Novel biomarker panel for the diagnosis and prognosis assessment of sepsis based on machine learning.

Association Between Changes in Plasma Metabolism and Clinical Outcomes of Sepsis.

Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units

Plasma Monocyte Chemoattractant Protein 1 as a Predictive Marker for Sepsis Prognosis: A Prospective Cohort Study

Identification of a novel sepsis prognosis model and analysis of possible drug application prospects: Based on scRNA-seq and RNA-seq data

Prognostic value of plasma 7-ketocholesterol in sepsis

Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis

Can We Improve Mortality Prediction in Patients with Sepsis in the Emergency Department?

Cuproptosis-Related Genes as Prognostic Biomarkers for Sepsis: Insights into Immune Function and Personalized Immunotherapy

Basal procalcitonin, C-reactive protein, interleukin-6, and presepsin for prediction of mortality in critically ill septic patients: a systematic review and meta-analysis

LASSO regression shows histidine and sphingosine 1 phosphate are linked to both sepsis mortality and endothelial damage

Lipocalin 10 as a New Prognostic Biomarker in Sepsis-Induced Myocardial Dysfunction and Mortality: A Pilot Study

Integrative analysis of metabolomics and transcriptomics to uncover biomarkers in sepsis